Ireland lacks consensus on neonatal vitamin K prophylaxis

BMJ

Volumn 323, Issue 7320, 2001, Pages 1068-

  Philip, Roy K ^a   Gul, Riswan ^a   Dunworth, Margo ^a   Keane, Noreen ^a  

^a Regional Maternity Hospital   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; VITAMIN K GROUP;

DRUG USE; HUMAN; IRELAND; NEWBORN; NEWBORN HEMORRHAGIC DISEASE; NOTE; PRACTICE GUIDELINE; HEALTH CARE POLICY; LETTER; MEDICAL PRACTICE; NEWBORN CARE; PRIORITY JOURNAL; PROPHYLAXIS;

ANTIFIBRINOLYTIC AGENTS; DRUG UTILIZATION REVIEW; HEMORRHAGIC DISEASE OF NEWBORN; HUMANS; INFANT, NEWBORN; IRELAND; PRACTICE GUIDELINES; VITAMIN K;

EID: 0035802667     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.323.7320.1068     Document Type: Letter

References (4)

1. Ansell P, Roman E, Fear N T, Renfrew M J. Vitamin K policies and midwifery practice: questionnaire survey. BMJ 2001; 322: 1148–1152. (12 May.)
2. Golding J, Greenwood R, Birmingham K, Mott M. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ 1992; 305: 341–346.
3. Parker L, Cole M, Craft A W, Hey E N. Neonatal vitamin K administration and childhood cancer in the north of England: retrospective case control study. BMJ 198;316: 189–193.
4. Jonville-Bera A P, Autret E. Study of vitamin K in neonates in France. Eur J Clin Pharmacol 1997; 52: 333–337.